Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T82665 | Target Info | |||
Target Name | Protein arginine methyltransferase 5 (PRMT5) | ||||
Synonyms | Shk1 kinase-binding protein 1 homolog; SKB1Hs; SKB1 homolog; SKB1; Protein arginine N-methyltransferase 5; Jak-binding protein 1; JBP1; IBP72; Histone-arginine N-methyltransferase PRMT5; HRMT1L5; 72 kDa ICln-binding protein | ||||
Target Type | Clinical trial Target | ||||
Gene Name | PRMT5 | ||||
Biochemical Class | Methyltransferase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Methylthioadenosine | Ligand Info | |||
Canonical SMILES | CSCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O | ||||
InChI | 1S/C11H15N5O3S/c1-20-2-5-7(17)8(18)11(19-5)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1 | ||||
InChIKey | WUUGFSXJNOTRMR-IOSLPCCCSA-N | ||||
PubChem Compound ID | 439176 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 7ZVU HUMAN PRMT5:MEP50 Crystal Structure With MTA and Fragment Bound | ||||||
Method | X-ray diffraction | Resolution | 1.95 Å | Mutation | No | [1] |
PDB Sequence |
RVSSGRDLNC
22 VPEIADTLGA32 VAKQGFDFLC42 MPVFHPRFKR52 EFIQEPAKNR62 PGPQTRSDLL 72 LSGRDWNTLI82 VGKLSPWIRP92 DSKVEKIRRN102 SEAAMLQELN112 FGAYLGLPAF 122 LLPLNQEDNT132 NLARVLTNHI142 HTGHHSSMFW152 MRVPLVAPED162 LRDDIIENAP 172 TTHTEEYSGE182 EKTWMWWHNF192 RTLCDYSKRI202 AVALEIGADL212 PSNHVIDRWL 222 GEPIKAAILP232 TSIFLTNKKG242 FPVLSKMHQR252 LIFRLLKLEV262 QFIITGTNHH 272 SEKEFCSYLQ282 YLEYLSQNRP292 PPNAYELFAK302 GYEDYLQSPL312 QPLMDNLESQ 322 TYEVFEKDPI332 KYSQYQQAIY342 KCLLDRVPEE352 EKDTNVQVLM362 VLGAGRGPLV 372 NASLRAAKQA382 DRRIKLYAVE392 KNPNAVVTLE402 NWQFEEWGSQ412 VTVVSSDMRE 422 WVAPEKADII432 VSELLGSFAD442 NELSPECLDG452 AQHFLKDDGV462 SIPGEYTSFL 472 APISSSKLYN482 EVRACREKDR492 DPEAQFEMPY502 VVRLHNFHQL512 SAPQPCFTFS 522 HPNRDPMIDN532 NRYCTLEFPV542 EVNTVLHGFA552 GYFETVLYQD562 ITLSIRPETH 572 SPGMFSWFPI582 LFPIKQPITV592 REGQTICVRF602 WRCSNSKKVW612 YEWAVTAPVC 622 SAIHNPTGRS632 YTIGL
|
|||||
|
PRO314
3.505
LEU315
3.355
LEU319
4.488
TYR324
2.651
PHE327
3.667
LEU364
4.787
GLY365
3.069
ALA366
4.706
GLY367
3.623
VAL391
4.543
|
|||||
PDB ID: 7ZUY HUMAN PRMT5:MEP50 Crystal Structure With MTA and Fragment Bound | ||||||
Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | No | [1] |
PDB Sequence |
RVSSGRDLNC
22 VPEIADTLGA32 VAKQGFDFLC42 MPVFHPRFKR52 EFIQEPAKNR62 PGPQTRSDLL 72 LSGRDWNTLI82 VGKLSPWIRP92 DSKVEKIRRN102 SEAAMLQELN112 FGAYLGLPAF 122 LLPLNQEDNT132 NLARVLTNHI142 HTGHHSSMFW152 MRVPLVAPED162 LRDDIIENAP 172 TTHTEEYSGE182 EKTWMWWHNF192 RTLCDYSKRI202 AVALEIGADL212 PSNHVIDRWL 222 GEPIKAAILP232 TSIFLTNKKG242 FPVLSKMHQR252 LIFRLLKLEV262 QFIITGTNHH 272 SEKEFCSYLQ282 YLEYLSQNRP292 PPNAYELFAK302 GYEDYLQSPL312 QPLMDNLESQ 322 TYEVFEKDPI332 KYSQYQQAIY342 KCLLDRVPEE352 EKDTNVQVLM362 VLGAGRGPLV 372 NASLRAAKQA382 DRRIKLYAVE392 KNPNAVVTLE402 NWQFEEWGSQ412 VTVVSSDMRE 422 WVAPEKADII432 VSELLGSFAD442 NELSPECLDG452 AQHFLKDDGV462 SIPGEYTSFL 472 APISSSKLYN482 EVRACREKDR492 DPEAQFEMPY502 VVRLHNFHQL512 SAPQPCFTFS 522 HPNRDPMIDN532 NRYCTLEFPV542 EVNTVLHGFA552 GYFETVLYQD562 ITLSIRPETH 572 SPGMFSWFPI582 LFPIKQPITV592 REGQTICVRF602 WRCSNSKKVW612 YEWAVTAPVC 622 SAIHNPTGRS632 YTIGL
|
|||||
|
PRO314
3.404
LEU315
3.362
ASP317
4.976
ASN318
4.979
LEU319
4.515
TYR324
2.562
PHE327
3.741
LEU364
4.810
GLY365
3.008
ALA366
4.754
GLY367
3.710
|
|||||
PDB ID: 7ZUP Human PRMT5:MEP50 structure with Fragment (Example 18) and MTA Bound | ||||||
Method | X-ray diffraction | Resolution | 2.01 Å | Mutation | No | [1] |
PDB Sequence |
RVSSGRDLNC
22 VPEIADTLGA32 VAKQGFDFLC42 MPVFHPRFKR52 EFIQEPAKNR62 PGPQTRSDLL 72 LSGRDWNTLI82 VGKLSPWIRP92 DSKVEKIRRN102 SEAAMLQELN112 FGAYLGLPAF 122 LLPLNQEDNT132 NLARVLTNHI142 HTGHHSSMFW152 MRVPLVAPED162 LRDDIIENAP 172 TTHTEEYSGE182 EKTWMWWHNF192 RTLCDYSKRI202 AVALEIGADL212 PSNHVIDRWL 222 GEPIKAAILP232 TSIFLTNKKG242 FPVLSKMHQR252 LIFRLLKLEV262 QFIITGTNHH 272 SEKEFCSYLQ282 YLEYLSQNRP292 PPNAYELFAK302 GYEDYLQSPL312 QPLMDNLESQ 322 TYEVFEKDPI332 KYSQYQQAIY342 KCLLDRVPEE352 EKDTNVQVLM362 VLGAGRGPLV 372 NASLRAAKQA382 DRRIKLYAVE392 KNPNAVVTLE402 NWQFEEWGSQ412 VTVVSSDMRE 422 WVAPEKADII432 VSELLGSFAD442 NELSPECLDG452 AQHFLKDDGV462 SIPGEYTSFL 472 APISSSKLYN482 EVRACREKDR492 DPEAQFEMPY502 VVRLHNFHQL512 SAPQPCFTFS 522 HPNRDPMIDN532 NRYCTLEFPV542 EVNTVLHGFA552 GYFETVLYQD562 ITLSIRPETH 572 SPGMFSWFPI582 LFPIKQPITV592 REGQTICVRF602 WRCSNSKKVW612 YEWAVTAPVC 622 SAIHNPTGRS632 YTIGL
|
|||||
|
PRO314
3.363
LEU315
3.326
ASP317
4.919
ASN318
4.972
LEU319
4.309
TYR324
2.520
PHE327
3.517
LEU364
4.870
GLY365
3.124
ALA366
4.778
GLY367
3.770
|
|||||
PDB ID: 7ZV2 HUMAN PRMT5:MEP50 Crystal Structure With MTA and Fragment Bound | ||||||
Method | X-ray diffraction | Resolution | 2.01 Å | Mutation | No | [1] |
PDB Sequence |
RVSSGRDLNC
22 VPEIADTLGA32 VAKQGFDFLC42 MPVFHPRFKR52 EFIQEPAKNR62 PGPQTRSDLL 72 LSGRDWNTLI82 VGKLSPWIRP92 DSKVEKIRRN102 SEAAMLQELN112 FGAYLGLPAF 122 LLPLNQEDNT132 NLARVLTNHI142 HTGHHSSMFW152 MRVPLVAPED162 LRDDIIENAP 172 TTHTEEYSGE182 EKTWMWWHNF192 RTLCDYSKRI202 AVALEIGADL212 PSNHVIDRWL 222 GEPIKAAILP232 TSIFLTNKKG242 FPVLSKMHQR252 LIFRLLKLEV262 QFIITGTNHH 272 SEKEFCSYLQ282 YLEYLSQNRP292 PPNAYELFAK302 GYEDYLQSPL312 QPLMDNLESQ 322 TYEVFEKDPI332 KYSQYQQAIY342 KCLLDRVPEE352 EKDTNVQVLM362 VLGAGRGPLV 372 NASLRAAKQA382 DRRIKLYAVE392 KNPNAVVTLE402 NWQFEEWGSQ412 VTVVSSDMRE 422 WVAPEKADII432 VSELLGSFAD442 NELSPECLDG452 AQHFLKDDGV462 SIPGEYTSFL 472 APISSSKLYN482 EVRACREKDR492 DPEAQFEMPY502 VVRLHNFHQL512 SAPQPCFTFS 522 HPNRDPMIDN532 NRYCTLEFPV542 EVNTVLHGFA552 GYFETVLYQD562 ITLSIRPETH 572 SPGMFSWFPI582 LFPIKQPITV592 REGQTICVRF602 WRCSNSKKVW612 YEWAVTAPVC 622 SAIHNPTGRS632 YTIGL
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .MTA or .MTA2 or .MTA3 or :3MTA;style chemicals stick;color identity;select .A:314 or .A:315 or .A:318 or .A:319 or .A:324 or .A:327 or .A:364 or .A:365 or .A:366 or .A:367 or .A:391 or .A:392 or .A:393 or .A:394 or .A:418 or .A:419 or .A:420 or .A:421 or .A:435 or .A:436 or .A:449; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PRO314
3.481
LEU315
3.368
ASN318
4.978
LEU319
4.637
TYR324
2.603
PHE327
3.784
LEU364
4.711
GLY365
2.962
ALA366
4.720
GLY367
3.671
VAL391
4.479
|
|||||
PDB ID: 7ZUU HUMAN PRMT5:MEP50 Crystal Structure With MTA and Fragment Bound | ||||||
Method | X-ray diffraction | Resolution | 2.09 Å | Mutation | No | [1] |
PDB Sequence |
RVSSGRDLNC
22 VPEIADTLGA32 VAKQGFDFLC42 MPVFHPRFKR52 EFIQEPAKNR62 PGPQTRSDLL 72 LSGRDWNTLI82 VGKLSPWIRP92 DSKVEKIRRN102 SEAAMLQELN112 FGAYLGLPAF 122 LLPLNQEDNT132 NLARVLTNHI142 HTGHHSSMFW152 MRVPLVAPED162 LRDDIIENAP 172 TTHTEEYSGE182 EKTWMWWHNF192 RTLCDYSKRI202 AVALEIGADL212 PSNHVIDRWL 222 GEPIKAAILP232 TSIFLTNKKG242 FPVLSKMHQR252 LIFRLLKLEV262 QFIITGTNHH 272 SEKEFCSYLQ282 YLEYLSQNRP292 PPNAYELFAK302 GYEDYLQSPL312 QPLMDNLESQ 322 TYEVFEKDPI332 KYSQYQQAIY342 KCLLDRVPEE352 EKDTNVQVLM362 VLGAGRGPLV 372 NASLRAAKQA382 DRRIKLYAVE392 KNPNAVVTLE402 NWQFEEWGSQ412 VTVVSSDMRE 422 WVAPEKADII432 VSELLGSFAD442 NELSPECLDG452 AQHFLKDDGV462 SIPGEYTSFL 472 APISSSKLYN482 EVRACREKDR492 DPEAQFEMPY502 VVRLHNFHQL512 SAPQPCFTFS 522 HPNRDPMIDN532 NRYCTLEFPV542 EVNTVLHGFA552 GYFETVLYQD562 ITLSIRPETH 572 SPGMFSWFPI582 LFPIKQPITV592 REGQTICVRF602 WRCSNSKKVW612 YEWAVTAPVC 622 SAIHNPTGRS632 YTIGL
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .MTA or .MTA2 or .MTA3 or :3MTA;style chemicals stick;color identity;select .A:314 or .A:315 or .A:319 or .A:324 or .A:327 or .A:364 or .A:365 or .A:366 or .A:367 or .A:391 or .A:392 or .A:393 or .A:394 or .A:418 or .A:419 or .A:420 or .A:421 or .A:435 or .A:436 or .A:449; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PRO314
3.519
LEU315
3.376
LEU319
4.444
TYR324
2.613
PHE327
3.885
LEU364
4.664
GLY365
3.049
ALA366
4.714
GLY367
3.668
VAL391
4.577
|
|||||
PDB ID: 7SER PRMT5/MEP50 with compound 30 bound | ||||||
Method | X-ray diffraction | Resolution | 2.14 Å | Mutation | No | [2] |
PDB Sequence |
RVSSGRDLNC
22 VPEIADTLGA32 VAKQGFDFLC42 MPVFHPRFKR52 EFIQEPAKNR62 PGPQTRSDLL 72 LSGRDWNTLI82 VGKLSPWIRP92 DSKVEKIRRN102 SEAAMLQELN112 FGAYLGLPAF 122 LLPLNQEDNT132 NLARVLTNHI142 HTGHHSSMFW152 MRVPLVAPED162 LRDDIIENAP 172 TTHTEEYSGE182 EKTWMWWHNF192 RTLCDYSKRI202 AVALEIGADL212 PSNHVIDRWL 222 GEPIKAAILP232 TSIFLTNKKG242 FPVLSKMHQR252 LIFRLLKLEV262 QFIITGTNHH 272 SEKEFCSYLQ282 YLEYLSQNRP292 PPNAYELFAK302 GYEDYLQSPL312 QPLMDNLESQ 322 TYEVFEKDPI332 KYSQYQQAIY342 KCLLDRVPEE352 EKDTNVQVLM362 VLGAGRGPLV 372 NASLRAAKQA382 DRRIKLYAVE392 KNPNAVVTLE402 NWQFEEWGSQ412 VTVVSSDMRE 422 WVAPEKADII432 VSELLGSFAD442 NELSPECLDG452 AQHFLKDDGV462 SIPGEYTSFL 472 APISSSKLYN482 EVRACREKDR492 DPEAQFEMPY502 VVRLHNFHQL512 SAPQPCFTFS 522 HPNRDPMIDN532 NRYCTLEFPV542 EVNTVLHGFA552 GYFETVLYQD562 ITLSIRPETH 572 SPGMFSWFPI582 LFPIKQPITV592 REGQTICVRF602 WRCSNSKKVW612 YEWAVTAPVC 622 SAIHNPTGRS632 YTIGL
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .MTA or .MTA2 or .MTA3 or :3MTA;style chemicals stick;color identity;select .A:314 or .A:315 or .A:318 or .A:319 or .A:324 or .A:327 or .A:364 or .A:365 or .A:366 or .A:367 or .A:391 or .A:392 or .A:393 or .A:394 or .A:418 or .A:419 or .A:420 or .A:421 or .A:435 or .A:436 or .A:444 or .A:449; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PRO314
3.593
LEU315
3.587
ASN318
4.988
LEU319
4.165
TYR324
2.586
PHE327
3.622
LEU364
4.691
GLY365
3.176
ALA366
4.736
GLY367
3.613
VAL391
4.468
|
|||||
PDB ID: 7ZVL HUMAN PRMT5:MEP50 Crystal Structure With MTA and Fragment Bound | ||||||
Method | X-ray diffraction | Resolution | 2.39 Å | Mutation | No | [1] |
PDB Sequence |
RVSSGRDLNC
22 VPEIADTLGA32 VAKQGFDFLC42 MPVFHPRFKR52 EFIQEPAKNR62 PGPQTRSDLL 72 LSGRDWNTLI82 VGKLSPWIRP92 DSKVEKIRRN102 SEAAMLQELN112 FGAYLGLPAF 122 LLPLNQEDNT132 NLARVLTNHI142 HTGHHSSMFW152 MRVPLVAPED162 LRDDIIENAP 172 TTHTEEYSGE182 EKTWMWWHNF192 RTLCDYSKRI202 AVALEIGADL212 PSNHVIDRWL 222 GEPIKAAILP232 TSIFLTNKKG242 FPVLSKMHQR252 LIFRLLKLEV262 QFIITGTNHH 272 SEKEFCSYLQ282 YLEYLSQNRP292 PPNAYELFAK302 GYEDYLQSPL312 QPLMDNLESQ 322 TYEVFEKDPI332 KYSQYQQAIY342 KCLLDRVPEE352 EKDTNVQVLM362 VLGAGRGPLV 372 NASLRAAKQA382 DRRIKLYAVE392 KNPNAVVTLE402 NWQFEEWGSQ412 VTVVSSDMRE 422 WVAPEKADII432 VSELLGSFAD442 NELSPECLDG452 AQHFLKDDGV462 SIPGEYTSFL 472 APISSSKLYN482 EVRACREKDR492 DPEAQFEMPY502 VVRLHNFHQL512 SAPQPCFTFS 522 HPNRDPMIDN532 NRYCTLEFPV542 EVNTVLHGFA552 GYFETVLYQD562 ITLSIRPETH 572 SPGMFSWFPI582 LFPIKQPITV592 REGQTICVRF602 WRCSNSKKVW612 YEWAVTAPVC 622 SAIHNPTGRS632 YTIGL
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .MTA or .MTA2 or .MTA3 or :3MTA;style chemicals stick;color identity;select .A:314 or .A:315 or .A:318 or .A:319 or .A:324 or .A:327 or .A:365 or .A:366 or .A:367 or .A:391 or .A:392 or .A:393 or .A:394 or .A:418 or .A:419 or .A:420 or .A:421 or .A:435 or .A:436 or .A:449; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PRO314
3.659
LEU315
3.579
ASN318
4.930
LEU319
3.899
TYR324
2.311
PHE327
3.038
GLY365
3.074
ALA366
4.402
GLY367
3.572
VAL391
4.342
|
|||||
PDB ID: 7ZUQ HUMAN PRMT5:MEP50 Crystal Structure With MTA and Fragment Bound | ||||||
Method | X-ray diffraction | Resolution | 2.48 Å | Mutation | No | [1] |
PDB Sequence |
RVSSGRDLNC
22 VPEIADTLGA32 VAKQGFDFLC42 MPVFHPRFKR52 EFIQEPAKNR62 PGPQTRSDLL 72 LSGRDWNTLI82 VGKLSPWIRP92 DSKVEKIRRN102 SEAAMLQELN112 FGAYLGLPAF 122 LLPLNQEDNT132 NLARVLTNHI142 HTGHHSSMFW152 MRVPLVAPED162 LRDDIIENAP 172 TTHTEEYSGE182 EKTWMWWHNF192 RTLCDYSKRI202 AVALEIGADL212 PSNHVIDRWL 222 GEPIKAAILP232 TSIFLTNKKG242 FPVLSKMHQR252 LIFRLLKLEV262 QFIITGTNHH 272 SEKEFCSYLQ282 YLEYLSQNRP292 PPNAYELFAK302 GYEDYLQSPL312 QPLMDNLESQ 322 TYEVFEKDPI332 KYSQYQQAIY342 KCLLDRVPEE352 EKDTNVQVLM362 VLGAGRGPLV 372 NASLRAAKQA382 DRRIKLYAVE392 KNPNAVVTLE402 NWQFEEWGSQ412 VTVVSSDMRE 422 WVAPEKADII432 VSELLGSFAD442 NELSPECLDG452 AQHFLKDDGV462 SIPGEYTSFL 472 APISSSKLYN482 EVRACREKDR492 DPEAQFEMPY502 VVRLHNFHQL512 SAPQPCFTFS 522 HPNRDPMIDN532 NRYCTLEFPV542 EVNTVLHGFA552 GYFETVLYQD562 ITLSIRPETH 572 SPGMFSWFPI582 LFPIKQPITV592 REGQTICVRF602 WRCSNSKKVW612 YEWAVTAPVC 622 SAIHNPTGRS632 YTIGL
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .MTA or .MTA2 or .MTA3 or :3MTA;style chemicals stick;color identity;select .A:314 or .A:315 or .A:318 or .A:319 or .A:324 or .A:327 or .A:364 or .A:365 or .A:366 or .A:367 or .A:391 or .A:392 or .A:393 or .A:394 or .A:418 or .A:419 or .A:420 or .A:421 or .A:435 or .A:436 or .A:444 or .A:449; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PRO314
3.453
LEU315
3.307
ASN318
5.000
LEU319
4.529
TYR324
2.547
PHE327
3.847
LEU364
4.662
GLY365
2.883
ALA366
4.682
GLY367
3.764
VAL391
4.388
|
|||||
PDB ID: 8CSG Human PRMT5:MEP50 structure with Fragment 1 and MTA Bound | ||||||
Method | X-ray diffraction | Resolution | 2.48 Å | Mutation | No | [1] |
PDB Sequence |
RVSSGRDLNC
22 VPEIADTLGA32 VAKQGFDFLC42 MPVFHPRFKR52 EFIQEPAKNR62 PGPQTRSDLL 72 LSGRDWNTLI82 VGKLSPWIRP92 DSKVEKIRRN102 SEAAMLQELN112 FGAYLGLPAF 122 LLPLNQEDNT132 NLARVLTNHI142 HTGHHSSMFW152 MRVPLVAPED162 LRDDIIENAP 172 TTHTEEYSGE182 EKTWMWWHNF192 RTLCDYSKRI202 AVALEIGADL212 PSNHVIDRWL 222 GEPIKAAILP232 TSIFLTNKKG242 FPVLSKMHQR252 LIFRLLKLEV262 QFIITGTNHH 272 SEKEFCSYLQ282 YLEYLSQNRP292 PPNAYELFAK302 GYEDYLQSPL312 QPLMDNLESQ 322 TYEVFEKDPI332 KYSQYQQAIY342 KCLLDRVPEE352 EKDTNVQVLM362 VLGAGRGPLV 372 NASLRAAKQA382 DRRIKLYAVE392 KNPNAVVTLE402 NWQFEEWGSQ412 VTVVSSDMRE 422 WVAPEKADII432 VSELLGSFAD442 NELSPECLDG452 AQHFLKDDGV462 SIPGEYTSFL 472 APISSSKLYN482 EVRACREKDR492 DPEAQFEMPY502 VVRLHNFHQL512 SAPQPCFTFS 522 HPNRDPMIDN532 NRYCTLEFPV542 EVNTVLHGFA552 GYFETVLYQD562 ITLSIRPETH 572 SPGMFSWFPI582 LFPIKQPITV592 REGQTICVRF602 WRCSNSKKVW612 YEWAVTAPVC 622 SAIHNPTGRS632 YTIGL
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .MTA or .MTA2 or .MTA3 or :3MTA;style chemicals stick;color identity;select .A:314 or .A:315 or .A:319 or .A:324 or .A:327 or .A:364 or .A:365 or .A:366 or .A:367 or .A:391 or .A:392 or .A:393 or .A:394 or .A:418 or .A:419 or .A:420 or .A:421 or .A:435 or .A:436 or .A:449; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PRO314
3.530
LEU315
3.507
LEU319
4.451
TYR324
2.753
PHE327
3.542
LEU364
4.995
GLY365
3.407
ALA366
4.931
GLY367
3.659
VAL391
4.428
|
|||||
PDB ID: 7SES PRMT5/MEP50 with compound 29 bound | ||||||
Method | X-ray diffraction | Resolution | 2.50 Å | Mutation | No | [2] |
PDB Sequence |
RVSSGRDLNC
22 VPEIADTLGA32 VAKQGFDFLC42 MPVFHPRFKR52 EFIQEPAKNR62 PGPQTRSDLL 72 LSGRDWNTLI82 VGKLSPWIRP92 DSKVEKIRRN102 SEAAMLQELN112 FGAYLGLPAF 122 LLPLNQEDNT132 NLARVLTNHI142 HTGHHSSMFW152 MRVPLVAPED162 LRDDIIENAP 172 TTHTEEYSGE182 EKTWMWWHNF192 RTLCDYSKRI202 AVALEIGADL212 PSNHVIDRWL 222 GEPIKAAILP232 TSIFLTNKKG242 FPVLSKMHQR252 LIFRLLKLEV262 QFIITGTNHH 272 SEKEFCSYLQ282 YLEYLSQNRP292 PPNAYELFAK302 GYEDYLQSPL312 QPLMDNLESQ 322 TYEVFEKDPI332 KYSQYQQAIY342 KCLLDRVPEE352 EKDTNVQVLM362 VLGAGRGPLV 372 NASLRAAKQA382 DRRIKLYAVE392 KNPNAVVTLE402 NWQFEEWGSQ412 VTVVSSDMRE 422 WVAPEKADII432 VSELLGSFAD442 NELSPECLDG452 AQHFLKDDGV462 SIPGEYTSFL 472 APISSSKLYN482 EVRACREKDR492 DPEAQFEMPY502 VVRLHNFHQL512 SAPQPCFTFS 522 HPNRDPMIDN532 NRYCTLEFPV542 EVNTVLHGFA552 GYFETVLYQD562 ITLSIRPETH 572 SPGMFSWFPI582 LFPIKQPITV592 REGQTICVRF602 WRCSNSKKVW612 YEWAVTAPVC 622 SAIHNPTGRS632 YTIGL
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .MTA or .MTA2 or .MTA3 or :3MTA;style chemicals stick;color identity;select .A:314 or .A:315 or .A:319 or .A:324 or .A:327 or .A:364 or .A:365 or .A:366 or .A:367 or .A:391 or .A:392 or .A:393 or .A:394 or .A:418 or .A:419 or .A:420 or .A:421 or .A:435 or .A:436 or .A:444 or .A:449; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PRO314
3.371
LEU315
3.469
LEU319
4.232
TYR324
2.988
PHE327
3.602
LEU364
4.785
GLY365
3.236
ALA366
4.710
GLY367
3.553
VAL391
4.460
GLU392
2.522
|
|||||
PDB ID: 8CTB Human PRMT5:MEP50 structure with Fragment 3 and MTA Bound | ||||||
Method | X-ray diffraction | Resolution | 2.61 Å | Mutation | No | [1] |
PDB Sequence |
RVSSGRDLNC
22 VPEIADTLGA32 VAKQGFDFLC42 MPVFHPRFKR52 EFIQEPAKNR62 PGPQTRSDLL 72 LSGRDWNTLI82 VGKLSPWIRP92 DSKVEKIRRN102 SEAAMLQELN112 FGAYLGLPAF 122 LLPLNQEDNT132 NLARVLTNHI142 HTGHHSSMFW152 MRVPLVAPED162 LRDDIIENAP 172 TTHTEEYSGE182 EKTWMWWHNF192 RTLCDYSKRI202 AVALEIGADL212 PSNHVIDRWL 222 GEPIKAAILP232 TSIFLTNKKG242 FPVLSKMHQR252 LIFRLLKLEV262 QFIITGTNHH 272 SEKEFCSYLQ282 YLEYLSQNRP292 PPNAYELFAK302 GYEDYLQSPL312 QPLMDNLESQ 322 TYEVFEKDPI332 KYSQYQQAIY342 KCLLDRVPEE352 EKDTNVQVLM362 VLGAGRGPLV 372 NASLRAAKQA382 DRRIKLYAVE392 KNPNAVVTLE402 NWQFEEWGSQ412 VTVVSSDMRE 422 WVAPEKADII432 VSELLGSFAD442 NELSPECLDG452 AQHFLKDDGV462 SIPGEYTSFL 472 APISSSKLYN482 EVRACREKDR492 DPEAQFEMPY502 VVRLHNFHQL512 SAPQPCFTFS 522 HPNRDPMIDN532 NRYCTLEFPV542 EVNTVLHGFA552 GYFETVLYQD562 ITLSIRPETH 572 SPGMFSWFPI582 LFPIKQPITV592 REGQTICVRF602 WRCSNSKKVW612 YEWAVTAPVC 622 SAIHNPTGRS632 YTIGL
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .MTA or .MTA2 or .MTA3 or :3MTA;style chemicals stick;color identity;select .A:314 or .A:315 or .A:319 or .A:324 or .A:327 or .A:364 or .A:365 or .A:366 or .A:367 or .A:391 or .A:392 or .A:393 or .A:394 or .A:418 or .A:419 or .A:420 or .A:421 or .A:435 or .A:436 or .A:449; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PRO314
3.359
LEU315
3.319
LEU319
4.566
TYR324
2.739
PHE327
3.807
LEU364
4.724
GLY365
3.222
ALA366
4.596
GLY367
3.726
VAL391
4.450
|
|||||
PDB ID: 7UY1 HUMAN PRMT5:MEP50 COMPLEX WITH MTA and Fragment 5 Bound | ||||||
Method | X-ray diffraction | Resolution | 2.66 Å | Mutation | No | [1] |
PDB Sequence |
RVSSGRDLNC
22 VPEIADTLGA32 VAKQGFDFLC42 MPVFHPRFKR52 EFIQEPAKNR62 PGPQTRSDLL 72 LSGRDWNTLI82 VGKLSPWIRP92 DSKVEKIRRN102 SEAAMLQELN112 FGAYLGLPAF 122 LLPLNQEDNT132 NLARVLTNHI142 HTGHHSSMFW152 MRVPLVAPED162 LRDDIIENAP 172 TTHTEEYSGE182 EKTWMWWHNF192 RTLCDYSKRI202 AVALEIGADL212 PSNHVIDRWL 222 GEPIKAAILP232 TSIFLTNKKG242 FPVLSKMHQR252 LIFRLLKLEV262 QFIITGTNHH 272 SFCSYLQYLE285 YLSQNRPPPN295 AYELFAKGYE305 DYLQSPLQPL315 MDNLESQTYE 325 VFEKDPIKYS335 QYQQAIYKCL345 LDRVPEEEKD355 TNVQVLMVLG365 AGRGPLVNAS 375 LRAAKQADRR385 IKLYAVEKNP395 NAVVTLENWQ405 FEEWGSQVTV415 VSSDMREWVA 425 PEKADIIVSE435 LLGSFADNEL445 SPECLDGAQH455 FLKDDGVSIP465 GEYTSFLAPI 475 SSSKLYNEVR485 ACREKDRDPE495 AQFEMPYVVR505 LHNFHQLSAP515 QPCFTFSHPN 525 RDPMIDNNRY535 CTLEFPVEVN545 TVLHGFAGYF555 ETVLYQDITL565 SIRPETHSPG 575 MFSWFPILFP585 IKQPITVREG595 QTICVRFWRC605 SNSKKVWYEW615 AVTAPVCSAI 625 HNPTGRSYTI635 GL
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .MTA or .MTA2 or .MTA3 or :3MTA;style chemicals stick;color identity;select .A:314 or .A:315 or .A:319 or .A:324 or .A:327 or .A:364 or .A:365 or .A:366 or .A:367 or .A:391 or .A:392 or .A:393 or .A:394 or .A:418 or .A:419 or .A:420 or .A:421 or .A:435 or .A:436 or .A:449; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PRO314
3.621
LEU315
3.564
LEU319
4.311
TYR324
2.593
PHE327
3.655
LEU364
4.964
GLY365
3.351
ALA366
4.664
GLY367
3.685
VAL391
4.549
|
|||||
PDB ID: 7UOH PRMT5/MEP50 crystal structure with MTA and an achiral, class 1, non-atropisomeric inhibitor bound | ||||||
Method | X-ray diffraction | Resolution | 2.70 Å | Mutation | No | [3] |
PDB Sequence |
RVSSGRDLNC
22 VPEIADTLGA32 VAKQGFDFLC42 MPVFHPRFKR52 EFIQEPAKNR62 PGPQTRSDLL 72 LSGRDWNTLI82 VGKLSPWIRP92 DSKVEKIRRN102 SEAAMLQELN112 FGAYLGLPAF 122 LLPLNQEDNT132 NLARVLTNHI142 HTGHHSSMFW152 MRVPLVAPED162 LRDDIIENAP 172 TTHTEEYSGE182 EKTWMWWHNF192 RTLCDYSKRI202 AVALEIGADL212 PSNHVIDRWL 222 GEPIKAAILP232 TSIFLTNKKG242 FPVLSKMHQR252 LIFRLLKLEV262 QFIITGTNHH 272 SEKEFCSYLQ282 YLEYLSQNRP292 PPNAYELFAK302 GYEDYLQSPL312 QPLMDNLESQ 322 TYEVFEKDPI332 KYSQYQQAIY342 KCLLDRVPEE352 EKDTNVQVLM362 VLGAGRGPLV 372 NASLRAAKQA382 DRRIKLYAVE392 KNPNAVVTLE402 NWQFEEWGSQ412 VTVVSSDMRE 422 WVAPEKADII432 VSELLGSFAD442 NELSPECLDG452 AQHFLKDDGV462 SIPGEYTSFL 472 APISSSKLYN482 EVRACREKDR492 DPEAQFEMPY502 VVRLHNFHQL512 SAPQPCFTFS 522 HPNRDPMIDN532 NRYCTLEFPV542 EVNTVLHGFA552 GYFETVLYQD562 ITLSIRPETH 572 SPGMFSWFPI582 LFPIKQPITV592 REGQTICVRF602 WRCSNSKKVW612 YEWAVTAPVC 622 SAIHNPTGRS632 YTIGL
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .MTA or .MTA2 or .MTA3 or :3MTA;style chemicals stick;color identity;select .A:314 or .A:315 or .A:319 or .A:324 or .A:327 or .A:364 or .A:365 or .A:366 or .A:367 or .A:391 or .A:392 or .A:393 or .A:394 or .A:418 or .A:419 or .A:420 or .A:421 or .A:435 or .A:436 or .A:444 or .A:449; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PRO314
3.552
LEU315
3.489
LEU319
4.264
TYR324
2.838
PHE327
3.586
LEU364
4.734
GLY365
3.186
ALA366
4.726
GLY367
3.728
VAL391
4.502
GLU392
2.511
|
|||||
PDB ID: 7UYF Human PRMT5:MEP50 structure with Fragment 4 and MTA Bound | ||||||
Method | X-ray diffraction | Resolution | 2.82 Å | Mutation | No | [1] |
PDB Sequence |
RVSSGRDLNC
22 VPEIADTLGA32 VAKQGFDFLC42 MPVFHPRFKR52 EFIQEPAKNR62 PGPQTRSDLL 72 LSGRDWNTLI82 VGKLSPWIRP92 DSKVEKIRRN102 SEAAMLQELN112 FGAYLGLPAF 122 LLPLNQEDNT132 NLARVLTNHI142 HTGHHSSMFW152 MRVPLVAPED162 LRDDIIENAP 172 TTHTEEYSGE182 EKTWMWWHNF192 RTLCDYSKRI202 AVALEIGADL212 PSNHVIDRWL 222 GEPIKAAILP232 TSIFLTNKKG242 FPVLSKMHQR252 LIFRLLKLEV262 QFIITGTNHH 272 KEFCSYLQYL284 EYLSQNRPPP294 NAYELFAKGY304 EDYLQSPLQP314 LMDNLESQTY 324 EVFEKDPIKY334 SQYQQAIYKC344 LLDRVPEEEK354 DTNVQVLMVL364 GAGRGPLVNA 374 SLRAAKQADR384 RIKLYAVEKN394 PNAVVTLENW404 QFEEWGSQVT414 VVSSDMREWV 424 APEKADIIVS434 ELLGSFADNE444 LSPECLDGAQ454 HFLKDDGVSI464 PGEYTSFLAP 474 ISSSKLYNEV484 RACREKDRDP494 EAQFEMPYVV504 RLHNFHQLSA514 PQPCFTFSHP 524 NRDPMIDNNR534 YCTLEFPVEV544 NTVLHGFAGY554 FETVLYQDIT564 LSIRPETHSP 574 GMFSWFPILF584 PIKQPITVRE594 GQTICVRFWR604 CSNSKKVWYE614 WAVTAPVCSA 624 IHNPTGRSYT634 IGL
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .MTA or .MTA2 or .MTA3 or :3MTA;style chemicals stick;color identity;select .A:314 or .A:315 or .A:319 or .A:324 or .A:327 or .A:364 or .A:365 or .A:366 or .A:367 or .A:391 or .A:392 or .A:393 or .A:394 or .A:418 or .A:419 or .A:420 or .A:421 or .A:435 or .A:436 or .A:449; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PRO314
3.681
LEU315
3.402
LEU319
4.429
TYR324
2.566
PHE327
3.634
LEU364
4.889
GLY365
3.185
ALA366
4.614
GLY367
3.794
VAL391
4.465
|
|||||
PDB ID: 5FA5 Crystal Structure of PRMT5:MEP50 in complex with MTA and H4 peptide | ||||||
Method | X-ray diffraction | Resolution | 2.34 Å | Mutation | No | [4] |
PDB Sequence |
RVSSGRDLNC
22 VPEIADTLGA32 VAKQGFDFLC42 MPVFHPRFKR52 EFIQEPAKNR62 PGPQTRSDLL 72 LSGRDWNTLI82 VGKLSPWIRP92 DSKVEKIRRN102 SEAAMLQELN112 FGAYLGLPAF 122 LLPLNQEDNT132 NLARVLTNHI142 HTGHHSSMFW152 MRVPLVAPED162 LRDDIIENAP 172 TTHTEEYSGE182 EKTWMWWHNF192 RTLCDYSKRI202 AVALEIGADL212 PSNHVIDRWL 222 GEPIKAAILP232 TSIFLTNKKG242 FPVLSKMHQR252 LIFRLLKLEV262 QFIITGTNHH 272 SEKEFCSYLQ282 YLEYLSQNRP292 PPNAYELFAK302 GYEDYLQSPL312 QPLMDNLESQ 322 TYEVFEKDPI332 KYSQYQQAIY342 KCLLDRVPEE352 EKDTNVQVLM362 VLGAGRGPLV 372 NASLRAAKQA382 DRRIKLYAVE392 KNPNAVVTLE402 NWQFEEWGSQ412 VTVVSSDMRE 422 WVAPEKADII432 VSELLGSFAD442 NELSPECLDG452 AQHFLKDDGV462 SIPGEYTSFL 472 APISSSKLYN482 EVRACREKDR492 DPEAQFEMPY502 VVRLHNFHQL512 SAPQPCFTFS 522 HPNRDPMIDN532 NRYCTLEFPV542 EVNTVLHGFA552 GYFETVLYQD562 ITLSIRPETH 572 SPGMFSWFPI582 LFPIKQPITV592 REGQTICVRF602 WRCSNSKKVW612 YEWAVTAPVC 622 SAIHNPTGRS632 YTIGL
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .MTA or .MTA2 or .MTA3 or :3MTA;style chemicals stick;color identity;select .A:314 or .A:315 or .A:319 or .A:324 or .A:327 or .A:364 or .A:365 or .A:366 or .A:367 or .A:391 or .A:392 or .A:393 or .A:394 or .A:418 or .A:419 or .A:420 or .A:421 or .A:435 or .A:436 or .A:444 or .A:449; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
PRO314
3.489
LEU315
3.505
LEU319
4.098
TYR324
2.649
PHE327
3.547
LEU364
4.792
GLY365
3.188
ALA366
4.839
GLY367
3.649
VAL391
4.336
GLU392
2.616
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Fragment optimization and elaboration strategies - the discovery of two lead series of PRMT5/MTA inhibitors from five fragment hits. RSC Med Chem. 2022 Sep 27;13(12):1549-1564. | ||||
REF 2 | Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5?MTA Complex for the Treatment of MTAP-Deleted Cancers. J Med Chem. 2022 Feb 10;65(3):1749-1766. | ||||
REF 3 | Design and evaluation of achiral, non-atropisomeric 4-(aminomethyl)phthalazin-1(2H)-one derivatives as novel PRMT5/MTA inhibitors. Bioorg Med Chem. 2022 Oct 1;71:116947. | ||||
REF 4 | Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5. Science. 2016 Mar 11;351(6278):1208-13. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.